Drug discovery is undergoing a transformational change. Early-stage target identification, lead generation and optimization work is now undertaken in a much more diverse set of organizations, involving biotechnology companies and academia as well as large pharmaceutical companies.

Anne Hersey, Stefan Senger, John Overington

Full publication: Future Medicinal Chemistry, Volume 4, No. 15, Pages 1865–1867